How RA Associated HLA-DR Molecules Contribute to the Development of Antibodies to Citrullinated Proteins: The Hapten Carrier Model
暂无分享,去创建一个
[1] I. Auger,et al. PAD4 Immunization Triggers Anti-Citrullinated Peptide Antibodies in Normal Mice: Analysis With Peptide Arrays , 2022, Frontiers in Immunology.
[2] I. Auger,et al. Do RA associated HLA-DR molecules bind citrullinated peptides or peptides from PAD4 to help the development of RA specific antibodies to citrullinated proteins? , 2020, Journal of autoimmunity.
[3] I. Auger,et al. Peptidylarginine Deiminase Autoimmunity and the Development of Anti–Citrullinated Protein Antibody in Rheumatoid Arthritis: The Hapten–Carrier Model , 2019, Arthritis & rheumatology.
[4] I. Auger,et al. Peptidyl arginine deiminase immunization induces anticitrullinated protein antibodies in mice with particular MHC types , 2017, Proceedings of the National Academy of Sciences.
[5] Morten Nielsen,et al. The Effect of a Tropical Climate on Available Nutrient Resources to Springs in Ophiolite-Hosted, Deep Biosphere Ecosystems in the Philippines , 2017, Front. Microbiol..
[6] R. Toes,et al. A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis , 2013, The Journal of experimental medicine.
[7] I. Auger,et al. New autoantibodies in early rheumatoid arthritis , 2013, Arthritis Research & Therapy.
[8] É. Pardoux,et al. HLA-DRB1 Genotypes and the Risk of Developing Anti Citrullinated Protein Antibody (ACPA) Positive Rheumatoid Arthritis , 2013, PloS one.
[9] J. Norris,et al. Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis. , 2010, Arthritis and rheumatism.
[10] I. Auger,et al. New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA , 2008, Annals of the rheumatic diseases.
[11] F. Breedveld,et al. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. , 2006, Arthritis and rheumatism.
[12] M. Sebbag,et al. Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen. , 2005, Arthritis and rheumatism.
[13] A. Suzuki,et al. Peptidylarginine deiminase 4 (PADI4) identified as a conformation‐dependent autoantigen in rheumatoid arthritis , 2005, Scandinavian journal of rheumatology.
[14] F. Breedveld,et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. , 2004, Arthritis and rheumatism.
[15] A. Sette,et al. Cutting Edge: The Conversion of Arginine to Citrulline Allows for a High-Affinity Peptide Interaction with the Rheumatoid Arthritis-Associated HLA-DRB1*0401 MHC Class II Molecule1 , 2003, The Journal of Immunology.
[16] P. Gregersen,et al. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. , 1987, Arthritis and rheumatism.
[17] I. Auger,et al. Rheumatoid arthritis-specific autoantibodies to peptidyl arginine deiminase type 4 inhibit citrullination of fibrinogen. , 2010, Arthritis and rheumatism.